Floyd Bloom, MD¹
Scripps Research Institute

Mark Brown, MD
Pfizer Corporation

Richard Chappell, MD^A
University of Wisconsin – Madison

Ellen Wright Clayton, MD JD^A
Vanderbilt University

Mark Corrigan, MD²
Sepracor, Inc.

Steven DeKosky, MD⁷
University of Pittsburgh

Jacqueline French, MD³
The Neurological Institute Hospital of the University of Pennsylvania

Alfred Goldberg, MD^A
Harvard University

J. Timothy Greenamyre, MD
Emory University

Alan Guttmacher, MD^A
National Human Genome Research Institute

Thomas Guttuso, MD⁴
State University of New York - Buffalo

Kathy Hudson, PhD^A
Johns Hopkins

Russell Katz, MD
Food and Drug Administration

Jeffrey Martin, Esq.^A
Parkinson’s Action Network

Henry McFarland, MD
National Institutes of Health

Dale Schenk, PhD⁶
Elan Pharmaceuticals

Ira Shoulson, MD^A
University of Rochester

Reisa Sperling, MD
Brigham and Women's Hospital

A. Jon Stoessl, MD^A
University of British Columbia

Robert Temple, MD^A
Food and Drug Administration

Marc Walton, MD PhD^A
Food and Drug Administration

Steven Warach, MD PhD
National Institute of Neurological Disorders and Stroke

All speakers are required to disclose any significant financial interest or relationship they have with the manufacturers of any commercial product or service that is discussed as part of their presentation. Those speakers who have indicated financial interest or relationships, or who are discussing a therapy that is unapproved or not labeled for the use discussed, are indicated with a superscript number to the right of their name. All speakers with an “A” have nothing to disclose. Speakers with no annotation after their names have not submitted disclosure information at the time of printing.

1 Founding CEO and Chairman of the Board, Neurome, Inc., La Jolla, CA
2 Employee at Sepracor, Inc.
3 Member of the Speaker’s Bureau for Pfizer, Novartis, Ortho-McNeil, Carter-Wallace, GlaxoSmithKline, Elan; provided paid consultation for GlaxoSmithKline, Pfizer, UCB Pharma, Elan, Shire-Richwood, Cyberonics, Schwarz Pharma, Wyeth-Ayerst; received research support from Carter-Wallace, Johnson and Johnson, Dianippon Pharmaceutical, Pfizer, GlaxoSmithKline, Schwabe Pharamceuticals, Abbott, UCB Pharma, Elan, Cyberonics, Medtronic, Schwarz Pharma, Wyeth-Ayerst
4 Not labeled for use under discussion – Gabapentin for hot flashes
6 Employee and stockholder at Elan Pharmaceuticals
7 Grant support from Eisai-Pfizer, Janssen; Consultant for Forrest, Eisai-Pfizer, Cephalon, Janssen, Novartis, AstraZeneca, Daiichi, Teva